
Yield10 Bioscience Inc
NASDAQ:YTEN

Intrinsic Value
Yield10 Bioscience, Inc. operates as an agricultural bioscience company. [ Read More ]
The intrinsic value of one
YTEN
stock under the Base Case scenario is
-18.08
USD.
Compared to the current market price of 0.25 USD,
Yield10 Bioscience Inc
is
Overvalued by 100%.

Valuation History
Yield10 Bioscience Inc

Intrinsic Value History...
Our system is conducting in-depth analyses to map out the stock's valuation journey. Thank you for waiting.
Fundamental Analysis
Balance Sheet Decomposition
Yield10 Bioscience Inc
Current Assets | 3.4m |
Cash & Short-Term Investments | 2.8m |
Other Current Assets | 600k |
Non-Current Assets | 2.6m |
PP&E | 2.4m |
Other Non-Current Assets | 200k |
Current Liabilities | 4m |
Accounts Payable | 400k |
Accrued Liabilities | 2.6m |
Other Current Liabilities | 1m |
Non-Current Liabilities | 1.7m |
Other Non-Current Liabilities | 1.7m |
YTEN Profitability Score
Profitability Due Diligence
Yield10 Bioscience Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.

Score
Yield10 Bioscience Inc's profitability score is 12/100. The higher the profitability score, the more profitable the company is.
YTEN Solvency Score
Solvency Due Diligence
Yield10 Bioscience Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.

Score
Yield10 Bioscience Inc's solvency score is 34/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
YTEN Price Targets Summary
Yield10 Bioscience Inc
Ownership
YTEN Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
YTEN Price
Yield10 Bioscience Inc
Average Annual Return | -37.76% |
Standard Deviation of Annual Returns | 27.97% |
Max Drawdown | -100% |
Market Capitalization | 3m USD |
Shares Outstanding | 11 864 000 |
Percentage of Shares Shorted | 1.91% |
Company Profile


Country
Industry
Market Cap
Dividend Yield
Description
Yield10 Bioscience, Inc. operates as an agricultural bioscience company. The company is headquartered in Woburn, Massachusetts and currently employs 29 full-time employees. The company went IPO on 2006-11-10. The firm is developing the oilseed Camelina sativa (Camelina) as a platform crop for large scale production of low-carbon sustainable seed products. The firm focuses on petroleum replacement markets, in which it is developing Camelina oil for use as a biofuel feedstock and polyhydroxyalkanoates (PHA) bioplastics produced in Camelina seed for use as a biodegradable bioplastic; and food and nutrition markets, in which it is developing omega-3 (DHA+EPA) oils produced in Camelina seed for aquaculture, nutraceuticals and protein meal for animal feed markets. The company is engaged in the development of elite Camelina germplasm exhibiting herbicide tolerance, disease resistance and other traits that form improved elite Camelina varieties for the biofuel market. The firm's new seed product traits include the PHA bioplastic trait developed by the Company and the omega-3 (DHA+EPA) oil traits.